MedTrace Logo

Comparison of Methacholine Bronchial Provocation With Wright and Devilbiss646 Nebulizers

NCT02502825 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2018-02-19

No results posted yet for this study

Summary

The purpose of this study is to compare the diagnostic validity (sensitivity and specificity) and evaluate the safety of 2-min Tidal Breathing methacholine bronchial provocation tests with the Wright and Devilbiss646 nebulizers in asthmatic in Guangzhou.

Conditions

Interventions

OTHER

methacholine

methacholine (0.03,0.06,0.125,0.5,1.0,2.0,4.0,8.0,16.0 mg/ml),Canada

DEVICE

Wright Nebulizer

nebulized for 2 minutes with an output of 0.13ml/min

DEVICE

Devilbiss646 Nebulizer

nebulized for 2 minutes with an output of 0.13ml/min

Sponsors & Collaborators

  • Firestone Institute for Respiratory Health

    collaborator OTHER

  • Guangzhou Institute of Respiratory Disease

    lead OTHER

Principal Investigators

  • Jinping Zheng · State Key Laboratory of Respiratory Disease; China Clinical Research Center of Respiratory Disease; First Affiliated Hospital of Guangzhou Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-07-31
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02502825 on ClinicalTrials.gov